<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:e sem="disease" ids="C0020497" disease_type="Disease or Syndrome" abbrv="">Caffey's disease</z:e> (infantile cortical <z:hpo ids='HP_0100774'>hyperostosis</z:hpo>) is considered to be a benign self-limiting disease of uncertain etiology that typically appears in early infancy </plain></SENT>
<SENT sid="1" pm="."><plain>The following case of <z:e sem="disease" ids="C0020497" disease_type="Disease or Syndrome" abbrv="">Caffey's disease</z:e> in a young girl is significant from 2 standpoints </plain></SENT>
<SENT sid="2" pm="."><plain>First, the course of the disease is atypical because of its severe recurrent nature </plain></SENT>
<SENT sid="3" pm="."><plain>The patient experienced 6 highly symptomatic episodes of cortical <z:hpo ids='HP_0100774'>hyperostosis</z:hpo> involving multiple new sites and previously healed lesions </plain></SENT>
<SENT sid="4" pm="."><plain>These recurrent episodes persisted into her fourth year of life </plain></SENT>
<SENT sid="5" pm="."><plain>In general, the reported cases of late recurrence of <z:e sem="disease" ids="C0020497" disease_type="Disease or Syndrome" abbrv="">Caffey's disease</z:e> describe patients with minimal symptoms and mild bony involvement </plain></SENT>
<SENT sid="6" pm="."><plain>The second area of significance involves the successful use of naproxen to control the symptoms and arrest the progression of the patient's disease </plain></SENT>
<SENT sid="7" pm="."><plain>Reports of <z:hpo ids='HP_0100774'>hyperostosis</z:hpo> in patients receiving <z:chebi fb="11" ids="26333">prostaglandin</z:chebi> E to maintain a <z:hpo ids='HP_0001643'>patent ductus arteriosus</z:hpo> suggest that <z:chebi fb="11" ids="26333">prostaglandins</z:chebi> may play a role in the etiology of <z:e sem="disease" ids="C0020497" disease_type="Disease or Syndrome" abbrv="">Caffey's disease</z:e> </plain></SENT>
<SENT sid="8" pm="."><plain>Given this evidence, it seems plausible that there may be a therapeutic role for <z:chebi fb="0" ids="49023">prostaglandin inhibitors</z:chebi> in the successful treatment of <z:e sem="disease" ids="C0020497" disease_type="Disease or Syndrome" abbrv="">Caffey's disease</z:e> </plain></SENT>
<SENT sid="9" pm="."><plain>The patient in this case had immediate and complete resolution of her symptoms while receiving naproxen with no recurrent bone formation while being treated with <z:chebi fb="3" ids="35472">antiinflammatory drugs</z:chebi> </plain></SENT>
</text></document>